RACHEL DUNSTON: Open Payments
NPI 1083383087 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 24 payments from 8 companies in 2025. Trend: 2023 $650 · 2024 $880 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $172 |
| Vanda Pharmaceuticals Inc. | 5 | $109 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $66 |
| ABBVIE INC. | 3 | $59 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
Products named: REXULTI, FANAPT, CAPLYTA, VRAYLAR, ABILIFY ASIMTUFII, INVEGA SUSTENNA, HETLIOZ, ABILIFY MAINTENA.
Industry payments across MO — which companies pay providers there.
